<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediterr J Hematol Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Mediterr J Hematol Infect Dis</journal-id><journal-id journal-id-type="publisher-id">Mediterranean Journal of Hematology and Infectious Diseases</journal-id><journal-title-group><journal-title>Mediterranean Journal of Hematology and Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2035-3006</issn><publisher><publisher-name>Universit&#x000e0; Cattolica del Sacro Cuore</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7340244</article-id><article-id pub-id-type="doi">10.4084/MJHID.2020.039</article-id><article-id pub-id-type="publisher-id">mjhid-12-1-e2020039</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Rigante</surname><given-names>Donato</given-names></name><xref ref-type="aff" rid="af1-mjhid-12-1-e2020039">1</xref><xref ref-type="aff" rid="af2-mjhid-12-1-e2020039">2</xref></contrib></contrib-group><aff id="af1-mjhid-12-1-e2020039">
<label>1</label>Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy</aff><aff id="af2-mjhid-12-1-e2020039">
<label>2</label>Universit&#x000e0; Cattolica Sacro Cuore, Rome, Italy</aff><author-notes><corresp id="c1-mjhid-12-1-e2020039">Correspondence to: Donato Rigante, MD, PhD, Department of Life Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit&#x000e0; Cattolica Sacro Cuore, Rome, Largo A. Gemelli 8, 00168 Rome, Italy. Tel: +39 06 30154475. Fax +39 06 3383211. E-mail: <email>donato.rigante@unicatt.it</email></corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>01</day><month>7</month><year>2020</year></pub-date><volume>12</volume><issue>1</issue><elocation-id>e2020039</elocation-id><history><date date-type="received"><day>21</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>17</day><month>6</month><year>2020</year></date></history><permissions><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0">https://creativecommons.org/licenses/by-nc/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Although the etiology of Kawasaki disease (KD) remains elusive, the available evidence indicates that the primum movens may be a dysregulated immune response to various microbial agents, leading to cytokine cascade and endothelial cell activation in patients with KD. Documented infections by different viruses in many individual cases have been largely reported and are discussed herein, but attempts to demonstrate their causative role in the distinctive KD scenario and KD epidemiological features have been disappointing. To date, no definite link has been irrefutably found between a single infection and KD.</p></abstract><kwd-group><kwd>Kawasaki disease</kwd><kwd>Viral infection</kwd><kwd>COVID-19</kwd><kwd>Child</kwd><kwd>Personalized medicine</kwd></kwd-group></article-meta></front><body><sec><title>The History of Kawasaki Disease</title><p>Almost 60 years ago, dr. Tomisaku Kawasaki noted, for the first time, a strange association of symptoms in a 4-year-old boy who was hospitalized at the Chiba University. The child had prolonged high fever, conjunctivitis, a widespread rash all over the body, and a bright-red tongue. However, he could not explain that disease, thinking to an allergy or any infectious diseases. Antibiotics were ineffective in treating that boy's symptoms, which subsided only after two weeks, also revealing specific desquamation of the fingers and toes. One year later, another child was hospitalized with those same symptoms, and dr. Kawasaki convinced himself that a mysterious illness could affect children. In 1967 he published a 44-page report of all hospitalized patients having that illness (that he named "acute febrile mucocutaneous lymph node syndrome") in the Japanese journal "Arerugi", usually dedicated to allergology, which was based on a diligent 6-year observation of 50 patients.<xref rid="b1-mjhid-12-1-e2020039" ref-type="bibr">1</xref> The eponym of Kawasaki disease (KD) was coined later, when an international journal offered a large amount of space to the description of this illness.<xref rid="b2-mjhid-12-1-e2020039" ref-type="bibr">2</xref> With some cases of sudden death occurring after an apparent resolution of KD, the issue started to gain more and more attention by the scientific community, and pediatric textbooks started to report on this condition.</p></sec><sec><title>A Systemic Vasculitis is the Key to Explain Kawasaki Disease</title><p>In plain terms, KD is a systemic vasculitis that mainly and typically occurs in infants and children less than five years: the most ominous complication of patients with KD is the occurrence of coronary artery abnormalities (CAA).<xref rid="b3-mjhid-12-1-e2020039" ref-type="bibr">3</xref> For this reason, KD is actually the leading cause of acquired pediatric heart disease in the developed world.<xref rid="b4-mjhid-12-1-e2020039" ref-type="bibr">4</xref> Many reports found that coronary arteritis occurred at the highest incidence, but that vasculitis developed at various sites throughout the body. Vascular lesions of KD may start in the tunica interna and externa of medium-sized muscular arteries, such as the coronary arteries, but also in arterioles, venules and capillaries, while inflammation disseminates to large arteries including the coronary arteries.<xref rid="b5-mjhid-12-1-e2020039" ref-type="bibr">5</xref>,<xref rid="b6-mjhid-12-1-e2020039" ref-type="bibr">6</xref> The media of affected vessels demonstrates edematous dissociation of the smooth muscle cells, while endothelial cell swelling and subendothelial edema are seen. An influx of neutrophils can be observed in the early stages of KD, with a rapid transition to large mononuclear cells in concert with lymphocytes and IgA plasma cells. Destruction of the internal elastic lamina and an eventual fibroblast proliferation can occur later. This active inflammation is replaced over several weeks to months by progressive fibrosis, with scar formation and remodeling.<xref rid="b7-mjhid-12-1-e2020039" ref-type="bibr">7</xref></p></sec><sec><title>The Clinical Chameleon of Kawasaki Disease</title><p>The classic diagnosis of KD has been historically based on the presence of 5 days of fever and a typical constellation of nonspecific clinical signs described in 1967 by dr. Kawasaki: upholding the diagnosis of KD requires that highly swinging fever is combined with at least 4 out of 5 "main" clinical features: [a] bilateral non-exudative conjunctivitis, [b] unilateral cervical lymphadenopathy, [c] polymorphous rash, [d] changes in the extremities (mainly in the form of angioedema) or in the perineal region (an early-onset desquamating rash) and [e] changes in the lips and/or oral cavity (dry fissured or reddened lips with a strawberry-like tongue).<xref rid="b8-mjhid-12-1-e2020039" ref-type="bibr">8</xref> Although the clinical clues of KD are easily recognizable, its underlying mechanisms are under deep investigation and remain poorly understood. Treatment of KD requires intravenous immunoglobulin (IVIG) and aspirin during the first ten days of illness, and its ultimate goal is avoiding the occurrence of CAA.<xref rid="b9-mjhid-12-1-e2020039" ref-type="bibr">9</xref> Mostly in the case of resistance to IVIG, inflammatory cells reach the vasa vasorum of coronary arteries with the risk of fragmentation of the internal lamina and damage to the media, resulting in the formation of CAA.<xref rid="b10-mjhid-12-1-e2020039" ref-type="bibr">10</xref> Higher values of C-reactive protein and younger age at onset are crucial points in determining respectively a failure in response to IVIG and a higher risk that the disease could be complicated by CAA.<xref rid="b11-mjhid-12-1-e2020039" ref-type="bibr">11</xref> Early ascertainment of non-responders to IVIG who might require additional therapies reducing the development of CAA is still a challenge.<xref rid="b12-mjhid-12-1-e2020039" ref-type="bibr">12</xref> With improved treatment methods and different drugs useful for refractory cases, the mortality rate of KD has dropped dramatically in recent years. However, despite increased awareness, the number of patients with KD presenting with incomplete or atypical features is increasing across the world. Incomplete cases of KD are characterized by less than four main clinical signs and atypical ones by a broad range of unusual clinical features, including aseptic meningitis, peripheral facial nerve palsy, liver impairment with jaundice, gallbladder hydrops, pneumonia-like disease, and even macrophage activation syndrome.<xref rid="b13-mjhid-12-1-e2020039" ref-type="bibr">13</xref>,<xref rid="b14-mjhid-12-1-e2020039" ref-type="bibr">14</xref></p></sec><sec><title>Different Potential Causes, One Resulting Disease</title><p>Despite extensive research, the etiology of KD is far to be unraveled, and no single pathognomonic clinical or laboratory finding for diagnosis has been identified. Indeed, the occurrence of KD in epidemics, as shown by nationwide epidemiologic surveys conducted with biennial frequency since 1970, reveals a potential relationship of KD with an infectious disease. A number of infectious agents, both bacterial and viral, have been isolated from patients with KD through the years,<xref rid="b15-mjhid-12-1-e2020039" ref-type="bibr">15</xref> but also non-infectious triggers are presumed to cause the disease.<xref rid="b16-mjhid-12-1-e2020039" ref-type="bibr">16</xref> Further KD characteristics such as high-grade fever, elevated acute-phase reactants, and elevated white blood cell count strongly suggest an infectious cause, and in particular, some characteristics may suggest a viral etiology, such as the self-limited course of KD, skin rash and conjunctivitis. A host of reports have clarified the distinct seasonality of KD in geographically distinct regions of the northern hemisphere, revealing that various triggers may be operating at different times of the year in various geospatial clustering of KD cases:<xref rid="b17-mjhid-12-1-e2020039" ref-type="bibr">17</xref> the seasonality of KD, with winter peaks in Japan and winter-spring predominance in the USA or in many other temperate areas, is highly suggestive of a viral etiology.<xref rid="b18-mjhid-12-1-e2020039" ref-type="bibr">18</xref> Shimizu et al. found a seasonal effect also on the response to IVIG treatment, with more patients manifesting resistance to IVIG in the warm seasons from May to October, but no differences in the general outcome of CAA.<xref rid="b19-mjhid-12-1-e2020039" ref-type="bibr">19</xref> Several epidemiological studies have also demonstrated that KD is frequently associated with a previous respiratory illness; however, no differences have been found in children stratified according to positive or negative respiratory viral testing; in fact, a positive test for respiratory viruses at the time of presentation should not be used to exclude the diagnosis of KD.<xref rid="b20-mjhid-12-1-e2020039" ref-type="bibr">20</xref></p></sec><sec><title>A Viral Infection to Switch on Kawasaki Disease</title><p>Searching for papers dedicated to KD and published in the last 35 years through PubMed (matching the terms "KD" and "virus" or "viral infection"), a list of viral agents hypothetically associated with KD can be drawn (see <xref rid="t1-mjhid-12-1-e2020039" ref-type="table">Table 1</xref>). Viral respiratory infections have been commonly found at the diagnosis of KD,<xref rid="b21-mjhid-12-1-e2020039" ref-type="bibr">21</xref> but they do not seem to affect patients' response to IVIG or influence the overall outcome.<xref rid="b22-mjhid-12-1-e2020039" ref-type="bibr">22</xref> The oldest reports date back to 1983 when rotavirus was found in the feces of children with KD<xref rid="b23-mjhid-12-1-e2020039" ref-type="bibr">23</xref> and to 1985 when parainfluenza virus and adenovirus were encountered.<xref rid="b24-mjhid-12-1-e2020039" ref-type="bibr">24</xref>,<xref rid="b25-mjhid-12-1-e2020039" ref-type="bibr">25</xref> A molecular-based adenovirus detection is relatively frequent in KD patients but should be interpreted with caution.<xref rid="b26-mjhid-12-1-e2020039" ref-type="bibr">26</xref> Indeed, 24 out of 25 children with adenovirus disease mimicking features of KD had a higher viral burden compared to those with KD and incidental adenovirus detection.<xref rid="b27-mjhid-12-1-e2020039" ref-type="bibr">27</xref> Anecdotal reports had been associated KD to human herpesvirus-6, parvovirus B19 and cytomegalovirus.<xref rid="b28-mjhid-12-1-e2020039" ref-type="bibr">28</xref>&#x02013;<xref rid="b31-mjhid-12-1-e2020039" ref-type="bibr">31</xref> However, the highest number of KD reports has been related to Epstein-Barr virus,<xref rid="b32-mjhid-12-1-e2020039" ref-type="bibr">32</xref>,<xref rid="b33-mjhid-12-1-e2020039" ref-type="bibr">33</xref> while KD cases with a concomitant infection caused by measles virus,<xref rid="b34-mjhid-12-1-e2020039" ref-type="bibr">34</xref> herpesvirus,<xref rid="b35-mjhid-12-1-e2020039" ref-type="bibr">35</xref> varicella-zoster virus,<xref rid="b36-mjhid-12-1-e2020039" ref-type="bibr">36</xref> influenza virus,<xref rid="b37-mjhid-12-1-e2020039" ref-type="bibr">37</xref>,<xref rid="b38-mjhid-12-1-e2020039" ref-type="bibr">38</xref> coxsackie virus,<xref rid="b39-mjhid-12-1-e2020039" ref-type="bibr">39</xref> and bocavirus are mostly isolated reports.<xref rid="b40-mjhid-12-1-e2020039" ref-type="bibr">40</xref> In particular for bocavirus, its nucleic acid was found in the nasopharyngeal, serum and stool samples from 5/16 (31.2%) patients with KD by reverse transcriptase-polymerase chain reaction (RT-PCR).<xref rid="b41-mjhid-12-1-e2020039" ref-type="bibr">41</xref> A prospective study by Bajolle et al. revealed that bocavirus was present in the serum of 3/32 (9%) and in the nasopharyngeal aspirate of 7/32 (21.8%) patients with KD, who probably had a previous bocavirus infection heralding KD.<xref rid="b42-mjhid-12-1-e2020039" ref-type="bibr">42</xref> Metagenomic sequencing and PCR detected torque teno virus 7 in only 2/11 (18%) patients with KD prospectively evaluated for one year,<xref rid="b43-mjhid-12-1-e2020039" ref-type="bibr">43</xref> while the most recent reports have highlighted the association of KD with Epstein-Barr virus,<xref rid="b44-mjhid-12-1-e2020039" ref-type="bibr">44</xref> parvovirus B19<xref rid="b45-mjhid-12-1-e2020039" ref-type="bibr">45</xref> and influenza virus.<xref rid="b46-mjhid-12-1-e2020039" ref-type="bibr">46</xref></p></sec><sec><title>The Outbreak of the New Coronavirus and Kawasaki Disease</title><p>The latest outbreak of the new coronavirus (HCoV) infection (named SARS-CoV-2) and the resulting pandemic threat to health worldwide has required strict social containment measures since February 2020, but has also spread the suspicion that this peculiar infection might trigger KD. As a matter of fact, HCoV has been associated with many reports of KD in the past: for instance, in a prospective casecontrolled study among Taiwanese children it was isolated in 7.1% of cases.<xref rid="b47-mjhid-12-1-e2020039" ref-type="bibr">47</xref> In 2005 Esper et al. identified a novel human HCoV, named "New Haven," in the respiratory secretions from 8/11 children with KD.<xref rid="b48-mjhid-12-1-e2020039" ref-type="bibr">48</xref> However, in Denver (Colorado, USA) the prevalence of HCoV-NL63 infection was not higher in KD patients compared with non-KD controls.<xref rid="b49-mjhid-12-1-e2020039" ref-type="bibr">49</xref> The contribution of HCoV-229E infection in the development of KD was also brought in question by Shirato et al., who used immunofluorescence testing to detect virus-neutralizing antibodies in 15 patients with KD before IVIG treatment.<xref rid="b50-mjhid-12-1-e2020039" ref-type="bibr">50</xref> The first case of KD associated with a concomitant SARS-CoV-2 infection was a 6-month infant hospitalized in Palo Alto (California, USA). However, the clinical significance of patient's positive testing remained unclear in the setting of KD.<xref rid="b51-mjhid-12-1-e2020039" ref-type="bibr">51</xref> Furthermore, a 5-year-old Afro-American boy was found to have KD-related signs in Jackson (Mississippi, USA) in combination with severe acute respiratory distress and shock syndrome, referred to SARS-CoV-2 infection detected via RT-PCR from his nasopharyngeal swab.<xref rid="b52-mjhid-12-1-e2020039" ref-type="bibr">52</xref> In April 2020, Verdoni et al. reported a 30-fold increased incidence of KD-like syndrome in children living in the Bergamo province of Italy, after the SARS-CoV-2 epidemic began in that same area, also showing higher rates of heart involvement and general features of macrophage activation or shock syndrome. The evidence of contact with the virus was confirmed by the presence of antibodies against SARS-CoV-2 in 8 out of 10 reported patients.<xref rid="b53-mjhid-12-1-e2020039" ref-type="bibr">53</xref> This study had the limitation of being based on a small case series, but suggested in-depth genetic analysis to investigate the potential susceptibility to KD after a triggering effect of SARS-CoV-2.</p><p>More recently, in the New York State (USA) during the period March-May 2020, a SARS-CoV-2-related multisystem inflammatory syndrome has been found in 95 patients younger than 21 years of all ethnic backgrounds: such patients presented an inflammatory vasculopathy showing some similarities to KD and toxic shock syndrome, and in particular nearly half of children 0 to 5 years, but only 12% of the adolescents 13 to 20 years of age had a discharge diagnosis of KD or atypical KD.<xref rid="b54-mjhid-12-1-e2020039" ref-type="bibr">54</xref> This study had the limitation of a presumed underestimation, possibly due to mild cases that did not require hospitalization.</p></sec><sec><title>The Evidence about Viral Contributors to Kawasaki Disease</title><p>Ultimately, viruses may be confounding bystanders in many descriptions of KD. However, intracytoplasmic inclusion bodies sharing morphologic features among several different RNA viral families have been found in autoptic tissues of patients deceased for KD.<xref rid="b55-mjhid-12-1-e2020039" ref-type="bibr">55</xref> Rowley et al. speculated that the development of KD could follow ubiquitous RNA viruses causing an asymptomatic infection or a very mild disease in the vast majority of children, but specifically "KD" in a subset of genetically selected people.<xref rid="b56-mjhid-12-1-e2020039" ref-type="bibr">56</xref> In addition, a pilot study investigating KD pathogenesis revealed specific viral signatures in 4/7 patients with KD via high-throughput sequencing on blood specimens, although 2 were corresponding to their vaccinal history (oral poliovirus and measles/mumps/rubella vaccine) and 2 to bocavirus and rhinovirus, which could suggest a temporal association with the disease.<xref rid="b57-mjhid-12-1-e2020039" ref-type="bibr">57</xref> Different studies have also found that an imbalance in the gut microbiota might interfere with the normal function of innate and adaptive immunity, and that variable microbiota interactions with environmental factors, mainly infectious agents, might drive the development of KD in a genetically susceptible child.<xref rid="b58-mjhid-12-1-e2020039" ref-type="bibr">58</xref> However, to date, no definite link has been irrefutably found between any viral agents and KD.</p></sec><sec><title>Conclusive Remarks</title><p>More than half a century after its discovery, it is frustrating to admit that KD is believed to be triggered by an infection, but that its direct unequivocal cause is unclear. Besides, at the age of 95, dr. Kawasaki remains very active and continues to support families with KD children through different nonprofit organizations. New theories about KD hypothesize that the disorder might be conceived as an autoinflammatory condition,<xref rid="b59-mjhid-12-1-e2020039" ref-type="bibr">59</xref> in which inflammation explodes without any involvement of autoimmune pathways and any sound relationship with microbial agents.<xref rid="b60-mjhid-12-1-e2020039" ref-type="bibr">60</xref>&#x02013;<xref rid="b62-mjhid-12-1-e2020039" ref-type="bibr">62</xref> Although KD causal factors are still elusive, the available evidence indicates that the primum movens may be a dysregulation of immune responses to various infectious agents, i.e., a kind of immune-mediated "echo" induced also by a viral infection. Even if several data might suggest that KD is an infection-related clinical syndrome, which can develop only in children with a predisposing genetic background, our knowledge on both the infectious agents involved and genetic characteristics of susceptible children remains poor. Understanding the molecular players responsible for dysregulation of the immune response in KD will foster the development of improved predictive tools and a more rational use of therapeutic agents to decrease the risk of CAA in all children with KD.</p></sec><sec><title>In Memoriam</title><p>On June 5, 2020 dr. Tomisaku Kawasaki passed away at the age of 95: the news had a profound impact on many clinicians who dedicated their professional lives studying Kawasaki disease. He was a true model to all pediatricians, not only with regard to his clinical acumen but especially concerning his vibrant humanity. This article is sincerely dedicated to the memory of Tomisaku Kawasaki.</p></sec></body><back><fn-group><fn id="fn1-mjhid-12-1-e2020039" fn-type="COI-statement"><p><bold>Competing interests:</bold> The authors declare no conflict of Interest.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-mjhid-12-1-e2020039"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T</given-names></name></person-group><article-title>Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children</article-title><source>Arerugi</source><year>1967</year><volume>16</volume><fpage>178</fpage><lpage>222</lpage><?supplied-pmid 6062087?><pub-id pub-id-type="pmid">6062087</pub-id></element-citation></ref><ref id="b2-mjhid-12-1-e2020039"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>T</given-names></name><name><surname>Kosaki</surname><given-names>F</given-names></name><name><surname>Okawa</surname><given-names>S</given-names></name><etal/></person-group><article-title>A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan</article-title><source>Pediatrics</source><year>1974</year><volume>54</volume><fpage>271</fpage><lpage>6</lpage><?supplied-pmid 4153258?><pub-id pub-id-type="pmid">4153258</pub-id></element-citation></ref><ref id="b3-mjhid-12-1-e2020039"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Gerber</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association</article-title><source>Pediatrics</source><year>2004</year><volume>114</volume><fpage>1708</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1542/peds.2004-2182</pub-id><?supplied-pmid 15574639?><pub-id pub-id-type="pmid">15574639</pub-id></element-citation></ref><ref id="b4-mjhid-12-1-e2020039"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcini</surname><given-names>F</given-names></name><name><surname>Capannini</surname><given-names>S</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name></person-group><article-title>Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas</article-title><source>Pediatr Rheumatol Online J</source><year>2011</year><volume>9</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1546-0096-9-17</pub-id><!--<pub-id pub-id-type="pmcid">PMC3163180</pub-id>--><?supplied-pmid 21774801?><pub-id pub-id-type="pmid">21774801</pub-id></element-citation></ref><ref id="b5-mjhid-12-1-e2020039"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>S</given-names></name><name><surname>Hazama</surname><given-names>F</given-names></name><name><surname>Kubagawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>General pathology of Kawasaki disease on the morphological alterations corresponding to the clinical manifestations</article-title><source>Acta Pathol Jpn</source><year>1980</year><volume>30</volume><fpage>681</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1827.1980.tb00966.x</pub-id><?supplied-pmid 7446109?><pub-id pub-id-type="pmid">7446109</pub-id></element-citation></ref><ref id="b6-mjhid-12-1-e2020039"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamashima</surname><given-names>Y</given-names></name></person-group><article-title>Kawasaki disease</article-title><source>Heart Vessels Suppl</source><year>1985</year><volume>1</volume><fpage>271</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/BF02072407</pub-id><?supplied-pmid 3843587?><pub-id pub-id-type="pmid">3843587</pub-id></element-citation></ref><ref id="b7-mjhid-12-1-e2020039"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Miyagawa-Tomita</surname><given-names>S</given-names></name><name><surname>Komatsu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study</article-title><source>Circulation</source><year>2000</year><volume>101</volume><fpage>2935</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.25.2935</pub-id><?supplied-pmid 10869266?><pub-id pub-id-type="pmid">10869266</pub-id></element-citation></ref><ref id="b8-mjhid-12-1-e2020039"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rosa</surname><given-names>G</given-names></name><name><surname>Pardeo</surname><given-names>M</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name></person-group><article-title>Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications</article-title><source>Eur Rev Med Pharmacol Sci</source><year>2007</year><volume>11</volume><fpage>301</fpage><lpage>8</lpage><?supplied-pmid 18074939?><pub-id pub-id-type="pmid">18074939</pub-id></element-citation></ref><ref id="b9-mjhid-12-1-e2020039"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchesi</surname><given-names>A</given-names></name><name><surname>Tarissi De Jacobis</surname><given-names>I</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name><etal/></person-group><article-title>Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase</article-title><source>Ital J Pediatr</source><year>2018</year><volume>44</volume><issue>1</issue><fpage>102</fpage><pub-id pub-id-type="doi">10.1186/s13052-018-0536-3</pub-id><!--<pub-id pub-id-type="pmcid">PMC6116535</pub-id>--><?supplied-pmid 30157897?><pub-id pub-id-type="pmid">30157897</pub-id></element-citation></ref><ref id="b10-mjhid-12-1-e2020039"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchesi</surname><given-names>A</given-names></name><name><surname>Tarissi De Jacobis</surname><given-names>I</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name><etal/></person-group><article-title>Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks</article-title><source>Ital J Pediatr</source><year>2018</year><volume>44</volume><issue>1</issue><fpage>103</fpage><pub-id pub-id-type="doi">10.1186/s13052-018-0529-2</pub-id><!--<pub-id pub-id-type="pmcid">PMC6116479</pub-id>--><?supplied-pmid 30157893?><pub-id pub-id-type="pmid">30157893</pub-id></element-citation></ref><ref id="b11-mjhid-12-1-e2020039"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name><name><surname>Valentini</surname><given-names>P</given-names></name><name><surname>Rizzo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome</article-title><source>Rheumatol Int</source><year>2010</year><volume>30</volume><fpage>841</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s00296-009-1337-1</pub-id><?supplied-pmid 20049445?><pub-id pub-id-type="pmid">20049445</pub-id></element-citation></ref><ref id="b12-mjhid-12-1-e2020039"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name><name><surname>Andreozzi</surname><given-names>L</given-names></name><name><surname>Fastiggi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome</article-title><source>Int J Mol Sci</source><year>2016</year><volume>17</volume><fpage>278</fpage><pub-id pub-id-type="doi">10.3390/ijms17030278</pub-id><!--<pub-id pub-id-type="pmcid">PMC4813142</pub-id>--><?supplied-pmid 26927060?><pub-id pub-id-type="pmid">26927060</pub-id></element-citation></ref><ref id="b13-mjhid-12-1-e2020039"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcini</surname><given-names>F</given-names></name><name><surname>Ozen</surname><given-names>S</given-names></name><name><surname>Magni-Manzoni</surname><given-names>S</given-names></name><etal/></person-group><article-title>Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study</article-title><source>Clin Exp Rheumatol</source><year>2012</year><volume>30</volume><fpage>799</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">23020938</pub-id></element-citation></ref><ref id="b14-mjhid-12-1-e2020039"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stabile</surname><given-names>A</given-names></name><name><surname>Bertoni</surname><given-names>B</given-names></name><name><surname>Ansuini</surname><given-names>V</given-names></name><etal/></person-group><article-title>The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age</article-title><source>Eur Rev Med Pharmacol Sci</source><year>2006</year><volume>10</volume><fpage>53</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16705949</pub-id></element-citation></ref><ref id="b15-mjhid-12-1-e2020039"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Principi</surname><given-names>N</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name><name><surname>Esposito</surname><given-names>S</given-names></name></person-group><article-title>The role of infection in Kawasaki syndrome</article-title><source>J Infect</source><year>2013</year><volume>67</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2013.04.004</pub-id><!--<pub-id pub-id-type="pmcid">PMC7132405</pub-id>--><?supplied-pmid 23603251?><pub-id pub-id-type="pmid">23603251</pub-id></element-citation></ref><ref id="b16-mjhid-12-1-e2020039"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name><name><surname>Tarantino</surname><given-names>G</given-names></name><name><surname>Valentini</surname><given-names>P</given-names></name></person-group><article-title>Non-infectious makers of Kawasaki syndrome: tangible or elusive triggers?</article-title><source>Immunol Res</source><year>2016</year><volume>64</volume><fpage>51</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1007/s12026-015-8679-4</pub-id><?supplied-pmid 26232895?><pub-id pub-id-type="pmid">26232895</pub-id></element-citation></ref><ref id="b17-mjhid-12-1-e2020039"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname><given-names>AH</given-names></name><name><surname>Shulman</surname><given-names>ST</given-names></name></person-group><article-title>The epidemiology and pathogenesis of Kawasaki disease</article-title><source>Front Pediatr</source><year>2018</year><volume>6</volume><fpage>374</fpage><pub-id pub-id-type="doi">10.3389/fped.2018.00374</pub-id><!--<pub-id pub-id-type="pmcid">PMC6298241</pub-id>--><?supplied-pmid 30619784?><pub-id pub-id-type="pmid">30619784</pub-id></element-citation></ref><ref id="b18-mjhid-12-1-e2020039"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>JC</given-names></name><name><surname>Herzog</surname><given-names>L</given-names></name><name><surname>Fabri</surname><given-names>O</given-names></name><etal/></person-group><article-title>Seasonality of Kawasaki disease: a global perspective</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>9</issue><fpage>e74529</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0074529</pub-id><!--<pub-id pub-id-type="pmcid">PMC3776809</pub-id>--><?supplied-pmid 24058585?><pub-id pub-id-type="pmid">24058585</pub-id></element-citation></ref><ref id="b19-mjhid-12-1-e2020039"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>D</given-names></name><name><surname>Hoshina</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>M</given-names></name><etal/></person-group><article-title>Seasonality in clinical courses of Kawasaki disease</article-title><source>Arch Dis Child</source><year>2019</year><volume>104</volume><fpage>694</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1136/archdischild-2018-315267</pub-id><?supplied-pmid 30413486?><pub-id pub-id-type="pmid">30413486</pub-id></element-citation></ref><ref id="b20-mjhid-12-1-e2020039"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnier</surname><given-names>JL</given-names></name><name><surname>Anderson</surname><given-names>MS</given-names></name><name><surname>Heizer</surname><given-names>HR</given-names></name><etal/></person-group><article-title>Concurrent respiratory viruses and Kawasaki disease</article-title><source>Pediatrics</source><year>2015</year><volume>136</volume><fpage>e609</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1542/peds.2015-0950</pub-id><?supplied-pmid 26304824?><pub-id pub-id-type="pmid">26304824</pub-id></element-citation></ref><ref id="b21-mjhid-12-1-e2020039"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan-Villegas</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>ML</given-names></name><name><surname>Ramilo</surname><given-names>O</given-names></name><etal/></person-group><article-title>Concomitant respiratory viral infections in children with Kawasaki disease</article-title><source>Pediatr Infect Dis J</source><year>2010</year><volume>29</volume><fpage>770</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1097/INF.0b013e3181dba70b</pub-id><!--<pub-id pub-id-type="pmcid">PMC2927322</pub-id>--><?supplied-pmid 20354462?><pub-id pub-id-type="pmid">20354462</pub-id></element-citation></ref><ref id="b22-mjhid-12-1-e2020039"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benseler</surname><given-names>SM</given-names></name><name><surname>McCrindle</surname><given-names>BW</given-names></name><name><surname>Silverman</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Infections and Kawasaki disease: implications for coronary artery outcome</article-title><source>Pediatrics</source><year>2005</year><volume>116</volume><fpage>e760</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1542/peds.2005-0559</pub-id><?supplied-pmid 16322132?><pub-id pub-id-type="pmid">16322132</pub-id></element-citation></ref><ref id="b23-mjhid-12-1-e2020039"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuno</surname><given-names>S</given-names></name><name><surname>Utagawa</surname><given-names>E</given-names></name><name><surname>Sugiura</surname><given-names>A</given-names></name></person-group><article-title>Association of rotavirus infection with Kawasaki syndrome</article-title><source>J Infect Dis</source><year>1983</year><volume>148</volume><fpage>177</fpage><pub-id pub-id-type="doi">10.1093/infdis/148.1.177</pub-id><?supplied-pmid 6309994?><pub-id pub-id-type="pmid">6309994</pub-id></element-citation></ref><ref id="b24-mjhid-12-1-e2020039"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Azimi</surname><given-names>P</given-names></name></person-group><article-title>Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection</article-title><source>Pediatr Infect Dis J</source><year>1985</year><volume>4</volume><fpage>100</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1097/00006454-198501000-00024</pub-id><?supplied-pmid 2982131?><pub-id pub-id-type="pmid">2982131</pub-id></element-citation></ref><ref id="b25-mjhid-12-1-e2020039"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Embil</surname><given-names>JA</given-names></name><name><surname>McFarlane</surname><given-names>ES</given-names></name><name><surname>Murphy</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Adenovirus type 2 isolated from a patient with fatal Kawasaki disease</article-title><source>Can Med Assoc J</source><year>1985</year><volume>132</volume><fpage>1400</fpage><?supplied-pmid 4005729?><pub-id pub-id-type="pmid">4005729</pub-id></element-citation></ref><ref id="b26-mjhid-12-1-e2020039"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaggi</surname><given-names>P</given-names></name><name><surname>Kajon</surname><given-names>AE</given-names></name><name><surname>Mejias</surname><given-names>A</given-names></name><etal/></person-group><article-title>Human adenovirus infection in Kawasaki disease: a confounding bystander?</article-title><source>Clin Infect Dis</source><year>2013</year><volume>56</volume><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1093/cid/cis807</pub-id><!--<pub-id pub-id-type="pmcid">PMC3732045</pub-id>--><?supplied-pmid 23011145?><pub-id pub-id-type="pmid">23011145</pub-id></element-citation></ref><ref id="b27-mjhid-12-1-e2020039"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Kajon</surname><given-names>AE</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Clinical and virologic characteristics may aid distinction of acute adenovirus disease from Kawasaki disease with incidental adenovirus detection</article-title><source>J Pediatr</source><year>2016</year><volume>170</volume><fpage>325</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2015.11.021</pub-id><?supplied-pmid 26707621?><pub-id pub-id-type="pmid">26707621</pub-id></element-citation></ref><ref id="b28-mjhid-12-1-e2020039"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okano</surname><given-names>M</given-names></name><name><surname>Luka</surname><given-names>J</given-names></name><name><surname>Thiele</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Human herpesvirus 6 infection and Kawasaki disease</article-title><source>J Clin Microbiol</source><year>1989</year><volume>27</volume><fpage>2379</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1128/JCM.27.10.2379-2380.1989</pub-id><!--<pub-id pub-id-type="pmcid">PMC267029</pub-id>--><?supplied-pmid 2555393?><pub-id pub-id-type="pmid">2555393</pub-id></element-citation></ref><ref id="b29-mjhid-12-1-e2020039"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagiwara</surname><given-names>K</given-names></name><name><surname>Komura</surname><given-names>H</given-names></name><name><surname>Kishi</surname><given-names>F</given-names></name><name><surname>Kaji</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name></person-group><article-title>Isolation of human herpesvirus-6 from an infant with Kawasaki disease</article-title><source>Eur J Pediatr</source><year>1992</year><volume>151</volume><fpage>867</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/BF01957946</pub-id><?supplied-pmid 1334835?><pub-id pub-id-type="pmid">1334835</pub-id></element-citation></ref><ref id="b30-mjhid-12-1-e2020039"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>JM</given-names></name><name><surname>Hansen</surname><given-names>LK</given-names></name><name><surname>Oxh&#x000f8;j</surname><given-names>H</given-names></name></person-group><article-title>Kawasaki disease associated with parvovirus B19 infection</article-title><source>Eur J Pediatr</source><year>1995</year><volume>154</volume><fpage>633</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1007/BF02079066</pub-id><?supplied-pmid 7588963?><pub-id pub-id-type="pmid">7588963</pub-id></element-citation></ref><ref id="b31-mjhid-12-1-e2020039"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usta Guc</surname><given-names>B</given-names></name><name><surname>Cengiz</surname><given-names>N</given-names></name><name><surname>Yildirim</surname><given-names>SV</given-names></name><etal/></person-group><article-title>Cytomegalovirus infection in a patient with atypical Kawasaki disease</article-title><source>Rheumatol Int</source><year>2008</year><volume>28</volume><fpage>387</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00296-007-0440-4</pub-id><!--<pub-id pub-id-type="pmcid">PMC7079931</pub-id>--><?supplied-pmid 17717671?><pub-id pub-id-type="pmid">17717671</pub-id></element-citation></ref><ref id="b32-mjhid-12-1-e2020039"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanegane</surname><given-names>H</given-names></name><name><surname>Tsuji</surname><given-names>T</given-names></name><name><surname>Seki</surname><given-names>H</given-names></name><etal/></person-group><article-title>Kawasaki disease with a concomitant primary Epstein-Barr virus infection</article-title><source>Acta Paediatr Jpn</source><year>1994</year><volume>36</volume><fpage>713</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/j.1442-200X.1994.tb03277.x</pub-id><?supplied-pmid 7871990?><pub-id pub-id-type="pmid">7871990</pub-id></element-citation></ref><ref id="b33-mjhid-12-1-e2020039"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuta</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Yanase</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Recurrence of Kawasaki disease and Epstein-Barr virus infection</article-title><source>J Infect Dis</source><year>1990</year><volume>162</volume><fpage>1215</fpage><pub-id pub-id-type="doi">10.1093/infdis/162.5.1215</pub-id><?supplied-pmid 2172398?><pub-id pub-id-type="pmid">2172398</pub-id></element-citation></ref><ref id="b34-mjhid-12-1-e2020039"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Herweijer</surname><given-names>TJ</given-names></name><name><surname>Scholvinck</surname><given-names>L</given-names></name><etal/></person-group><article-title>Kawasaki disease associated with measles virus infection in a monozygotic twin</article-title><source>Pediatr Infect Dis J</source><year>2000</year><volume>19</volume><fpage>350</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1097/00006454-200004000-00018</pub-id><?supplied-pmid 10783028?><pub-id pub-id-type="pmid">10783028</pub-id></element-citation></ref><ref id="b35-mjhid-12-1-e2020039"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shingadia</surname><given-names>D</given-names></name><name><surname>Bose</surname><given-names>A</given-names></name><name><surname>Booy</surname><given-names>R</given-names></name></person-group><article-title>Could a herpesvirus be the cause of Kawasaki disease?</article-title><source>Lancet Infect Dis</source><year>2002</year><volume>2</volume><fpage>310</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(02)00265-7</pub-id><pub-id pub-id-type="pmid">12062997</pub-id></element-citation></ref><ref id="b36-mjhid-12-1-e2020039"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Huang</surname><given-names>HP</given-names></name></person-group><article-title>Kawasaki disease associated with chickenpox: report of two sibling cases</article-title><source>Acta Paediatr Taiwan</source><year>2004</year><volume>45</volume><fpage>94</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15335119</pub-id></element-citation></ref><ref id="b37-mjhid-12-1-e2020039"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>AV</given-names></name><name><surname>Jones</surname><given-names>KD</given-names></name><name><surname>Buckley</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Kawasaki disease coincident with influenza A H1N1/09 infection</article-title><source>Pediatr Int</source><year>2011</year><volume>53</volume><fpage>e1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1111/j.1442-200X.2010.03280.x</pub-id><!--<pub-id pub-id-type="pmcid">PMC7167673</pub-id>--><?supplied-pmid 21342333?><pub-id pub-id-type="pmid">21342333</pub-id></element-citation></ref><ref id="b38-mjhid-12-1-e2020039"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Influenza infection and Kawasaki disease</article-title><source>Rev Soc Bras Med Trop</source><year>2015</year><volume>48</volume><fpage>243</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1590/0037-8682-0091-2015</pub-id><?supplied-pmid 26108000?><pub-id pub-id-type="pmid">26108000</pub-id></element-citation></ref><ref id="b39-mjhid-12-1-e2020039"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name><name><surname>Cantarini</surname><given-names>L</given-names></name><name><surname>Piastra</surname><given-names>M</given-names></name><etal/></person-group><article-title>Kawasaki syndrome and concurrent Coxsackie-virus B3 infection</article-title><source>Rheumatol Int</source><year>2012</year><volume>32</volume><fpage>4037</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1007/s00296-010-1613-0</pub-id><!--<pub-id pub-id-type="pmcid">PMC7080020</pub-id>--><?supplied-pmid 21052673?><pub-id pub-id-type="pmid">21052673</pub-id></element-citation></ref><ref id="b40-mjhid-12-1-e2020039"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalano-Pons</surname><given-names>C</given-names></name><name><surname>Giraud</surname><given-names>C</given-names></name><name><surname>Rozenberg</surname><given-names>F</given-names></name><etal/></person-group><article-title>Detection of human bocavirus in children with Kawasaki disease</article-title><source>Clin Microbiol Infect</source><year>2007</year><volume>13</volume><fpage>1220</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01827.x</pub-id><?supplied-pmid 17850342?><pub-id pub-id-type="pmid">17850342</pub-id></element-citation></ref><ref id="b41-mjhid-12-1-e2020039"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>RA</given-names></name><name><surname>Nogueira</surname><given-names>CS</given-names></name><name><surname>Granja</surname><given-names>S</given-names></name><etal/></person-group><source>Kawasaki disease and human bocavirus-potential association?</source><pub-id pub-id-type="doi">10.1016/j.jmii.2011.01.016</pub-id><?supplied-pmid 21524620?><pub-id pub-id-type="pmid">21524620</pub-id></element-citation></ref><ref id="b42-mjhid-12-1-e2020039"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajolle</surname><given-names>F</given-names></name><name><surname>Meritet</surname><given-names>JF</given-names></name><name><surname>Rozenberg</surname><given-names>F</given-names></name><etal/></person-group><article-title>Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study"</article-title><source>Pathol Biol (Paris)</source><year>2014</year><volume>62</volume><fpage>365</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.patbio.2014.06.002</pub-id><?supplied-pmid 25193448?><pub-id pub-id-type="pmid">25193448</pub-id></element-citation></ref><ref id="b43-mjhid-12-1-e2020039"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thissen</surname><given-names>JB</given-names></name><name><surname>Isshiki</surname><given-names>M</given-names></name><name><surname>Jaing</surname><given-names>C</given-names></name><etal/></person-group><article-title>A novel variant of torque teno virus 7 identified in patients with Kawasaki disease</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><issue>12</issue><fpage>e0209683</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0209683</pub-id><!--<pub-id pub-id-type="pmcid">PMC6310298</pub-id>--><?supplied-pmid 30592753?><pub-id pub-id-type="pmid">30592753</pub-id></element-citation></ref><ref id="b44-mjhid-12-1-e2020039"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggio</surname><given-names>MC</given-names></name><name><surname>Fabiano</surname><given-names>C</given-names></name><name><surname>Corsello</surname><given-names>G</given-names></name></person-group><article-title>Kawasaki disease triggered by EBV virus in a child with familial Mediterranean fever</article-title><source>Ital J Pediatr</source><year>2019</year><volume>45</volume><fpage>129</fpage><pub-id pub-id-type="doi">10.1186/s13052-019-0717-8</pub-id><!--<pub-id pub-id-type="pmcid">PMC6798734</pub-id>--><?supplied-pmid 31627741?><pub-id pub-id-type="pmid">31627741</pub-id></element-citation></ref><ref id="b45-mjhid-12-1-e2020039"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggio</surname><given-names>MC</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Alaimo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings</article-title><source>J Med Case Rep</source><year>2019</year><volume>13</volume><fpage>104</fpage><pub-id pub-id-type="doi">10.1186/s13256-019-2028-5</pub-id><!--<pub-id pub-id-type="pmcid">PMC6480815</pub-id>--><?supplied-pmid 31014402?><pub-id pub-id-type="pmid">31014402</pub-id></element-citation></ref><ref id="b46-mjhid-12-1-e2020039"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Deng</surname><given-names>HL</given-names></name><etal/></person-group><article-title>Influenza A (H1N1) pdm09 virus infection in a patient with incomplete Kawasaki disease: A case report</article-title><source>Medicine (Baltimore)</source><year>2019</year><volume>98</volume><issue>15</issue><fpage>e15009</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000015009</pub-id><!--<pub-id pub-id-type="pmcid">PMC6485757</pub-id>--><?supplied-pmid 30985646?><pub-id pub-id-type="pmid">30985646</pub-id></element-citation></ref><ref id="b47-mjhid-12-1-e2020039"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>LY</given-names></name><name><surname>Lu</surname><given-names>CY</given-names></name><name><surname>Shao</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Viral infections associated with Kawasaki disease</article-title><source>J Formos Med Assoc</source><year>2014</year><volume>113</volume><fpage>148</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.jfma.2013.12.008</pub-id><!--<pub-id pub-id-type="pmcid">PMC7125523</pub-id>--><?supplied-pmid 24495555?><pub-id pub-id-type="pmid">24495555</pub-id></element-citation></ref><ref id="b48-mjhid-12-1-e2020039"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esper</surname><given-names>F</given-names></name><name><surname>Shapiro</surname><given-names>ED</given-names></name><name><surname>Weibel</surname><given-names>C</given-names></name><etal/></person-group><article-title>Association between a novel human coronavirus and Kawasaki disease</article-title><source>J Infect Dis</source><year>2005</year><volume>191</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1086/428291</pub-id><!--<pub-id pub-id-type="pmcid">PMC7199489</pub-id>--><?supplied-pmid 15655771?><pub-id pub-id-type="pmid">15655771</pub-id></element-citation></ref><ref id="b49-mjhid-12-1-e2020039"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez</surname><given-names>SR</given-names></name><name><surname>Anderson</surname><given-names>MS</given-names></name><name><surname>Glod&#x000e9;</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><fpage>1697</fpage><lpage>01</lpage><pub-id pub-id-type="doi">10.1086/509509</pub-id><!--<pub-id pub-id-type="pmcid">PMC7199878</pub-id>--><?supplied-pmid 17109341?><pub-id pub-id-type="pmid">17109341</pub-id></element-citation></ref><ref id="b50-mjhid-12-1-e2020039"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirato</surname><given-names>K</given-names></name><name><surname>Imada</surname><given-names>Y</given-names></name><name><surname>Kawase</surname><given-names>M</given-names></name><etal/></person-group><article-title>Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease</article-title><source>J Med Virol</source><year>2014</year><volume>86</volume><fpage>2146</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/jmv.23950</pub-id><!--<pub-id pub-id-type="pmcid">PMC7166330</pub-id>--><?supplied-pmid 24760654?><pub-id pub-id-type="pmid">24760654</pub-id></element-citation></ref><ref id="b51-mjhid-12-1-e2020039"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>VG</given-names></name><name><surname>Mills</surname><given-names>M</given-names></name><name><surname>Suarez</surname><given-names>D</given-names></name><etal/></person-group><article-title>COVID-19 and Kawasaki disease: novel virus and novel case</article-title><source>Hosp Pediatr</source><year>2020</year><volume>10</volume><fpage>537</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1542/hpeds.2020-0123</pub-id><?supplied-pmid 32265235?><pub-id pub-id-type="pmid">32265235</pub-id></element-citation></ref><ref id="b52-mjhid-12-1-e2020039"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Figueroa</surname><given-names>EI</given-names></name><name><surname>Santos</surname><given-names>R</given-names></name><name><surname>Simpson</surname><given-names>S</given-names></name><etal/></person-group><article-title>Incomplete Kawasaki Disease in a child with Covid-19</article-title><source>Indian Pediatr</source><year>2020</year><month>5</month><volume>9</volume><comment>S097475591600179</comment><?supplied-pmid 32393680?><pub-id pub-id-type="pmid">32393680</pub-id></element-citation></ref><ref id="b53-mjhid-12-1-e2020039"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdoni</surname><given-names>L</given-names></name><name><surname>Mazza</surname><given-names>A</given-names></name><name><surname>Gervasoni</surname><given-names>A</given-names></name><etal/></person-group><article-title>An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study</article-title><source>Lancet Lancet</source><year>2020</year><volume>395</volume><issue>10239</issue><fpage>1771</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)31103-X</pub-id><?supplied-pmid 32410760?><pub-id pub-id-type="pmid">32410760</pub-id></element-citation></ref><ref id="b54-mjhid-12-1-e2020039"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufort</surname><given-names>EM</given-names></name><name><surname>Koumans</surname><given-names>EH</given-names></name><name><surname>Chow</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Multisystem inflammatory syndrome in children in New York State</article-title><source>N Engl J Med</source><year>2020</year><month>6</month><day>29</day><pub-id pub-id-type="doi">10.1056/NEJMoa2021756</pub-id><?supplied-pmid 32598830?><pub-id pub-id-type="pmid">32598830</pub-id></element-citation></ref><ref id="b55-mjhid-12-1-e2020039"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname><given-names>AH</given-names></name><name><surname>Baker</surname><given-names>SC</given-names></name><name><surname>Shulman</surname><given-names>ST</given-names></name><etal/></person-group><article-title>RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e1582</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0001582</pub-id><!--<pub-id pub-id-type="pmcid">PMC2216059</pub-id>--><?supplied-pmid 18270572?><pub-id pub-id-type="pmid">18270572</pub-id></element-citation></ref><ref id="b56-mjhid-12-1-e2020039"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowley</surname><given-names>AH</given-names></name><name><surname>Baker</surname><given-names>SC</given-names></name><name><surname>Shulman</surname><given-names>ST</given-names></name><etal/></person-group><article-title>Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease</article-title><source>J Infect Dis</source><year>2011</year><volume>203</volume><fpage>1021</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiq136</pub-id><!--<pub-id pub-id-type="pmcid">PMC3068030</pub-id>--><?supplied-pmid 21402552?><pub-id pub-id-type="pmid">21402552</pub-id></element-citation></ref><ref id="b57-mjhid-12-1-e2020039"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L'Huillier</surname><given-names>AG</given-names></name><name><surname>Brito</surname><given-names>F</given-names></name><name><surname>Wagner</surname><given-names>N</given-names></name><etal/></person-group><article-title>Identification of viral signatures using high-throughput sequencing on blood of patients with Kawasaki disease</article-title><source>Front Pediatr</source><year>2019</year><volume>7</volume><fpage>524</fpage><pub-id pub-id-type="doi">10.3389/fped.2019.00524</pub-id><!--<pub-id pub-id-type="pmcid">PMC6930886</pub-id>--><?supplied-pmid 31921732?><pub-id pub-id-type="pmid">31921732</pub-id></element-citation></ref><ref id="b58-mjhid-12-1-e2020039"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>S</given-names></name><name><surname>Polinori</surname><given-names>I</given-names></name><name><surname>Rigante</surname><given-names>D</given-names></name></person-group><article-title>The gut microbiota-host partnership as a potential driver of Kawasaki syndrome</article-title><source>Front Pediatr</source><year>2019</year><volume>7</volume><fpage>124</fpage><pub-id pub-id-type="doi">10.3389/fped.2019.00124</pub-id><!--<pub-id pub-id-type="pmcid">PMC6460951</pub-id>--><?supplied-pmid 31024869?><pub-id pub-id-type="pmid">31024869</pub-id></element-citation></ref><ref id="b59-mjhid-12-1-e2020039"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrani</surname><given-names>E</given-names></name><name><surname>Burns</surname><given-names>JC</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name></person-group><article-title>How should we classify Kawasaki disease?</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>2974</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.02974</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02974</pub-id><!--<pub-id pub-id-type="pmcid">PMC6302019</pub-id>--><?supplied-pmid 30619331?><pub-id pub-id-type="pmid">30619331</pub-id></element-citation></ref><ref id="b60-mjhid-12-1-e2020039"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name></person-group><article-title>A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner</article-title><source>Expert Rev Clin Immunol</source><year>2017</year><volume>13</volume><fpage>571</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1080/1744666X.2017.1280396</pub-id><?supplied-pmid 28064547?><pub-id pub-id-type="pmid">28064547</pub-id></element-citation></ref><ref id="b61-mjhid-12-1-e2020039"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name></person-group><article-title>The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children</article-title><source>Mediterr J Hematol Infect Dis</source><year>2018</year><volume>10</volume><issue>1</issue><fpage>e2018067</fpage><pub-id pub-id-type="doi">10.4084/mjhid.2018.067</pub-id><!--<pub-id pub-id-type="pmcid">PMC6223578</pub-id>--><?supplied-pmid 30416699?><pub-id pub-id-type="pmid">30416699</pub-id></element-citation></ref><ref id="b62-mjhid-12-1-e2020039"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigante</surname><given-names>D</given-names></name><name><surname>Frediani</surname><given-names>B</given-names></name><name><surname>Galeazzi</surname><given-names>M</given-names></name><etal/></person-group><article-title>From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases</article-title><source>Biomed Res Int</source><year>2013</year><volume>2013</volume><comment>485103 </comment><pub-id pub-id-type="doi">10.1155/2013/485103</pub-id><!--<pub-id pub-id-type="pmcid">PMC3736491</pub-id>--><?supplied-pmid 23971037?><pub-id pub-id-type="pmid">23971037</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-mjhid-12-1-e2020039" position="float"><label>Table 1</label><caption><p>Viral agents associated with Kawasaki disease.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Viral agent</th><th valign="middle" align="center" rowspan="1" colspan="1">References</th><th valign="middle" align="center" rowspan="1" colspan="1">Year</th><th valign="middle" align="center" rowspan="1" colspan="1">First authors</th><th valign="middle" align="center" rowspan="1" colspan="1">Modality of study</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Rotavirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b23-mjhid-12-1-e2020039" ref-type="bibr">23</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1983</td><td valign="middle" align="center" rowspan="1" colspan="1">Matsuno</td><td valign="middle" align="center" rowspan="1" colspan="1">Hemagglutination on feces</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Parainfluenza virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b24-mjhid-12-1-e2020039" ref-type="bibr">24</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1985</td><td valign="middle" align="center" rowspan="1" colspan="1">Johnson</td><td valign="middle" align="center" rowspan="1" colspan="1">Culture on pharyngeal swab</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adenovirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b25-mjhid-12-1-e2020039" ref-type="bibr">25</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1985</td><td valign="middle" align="center" rowspan="1" colspan="1">Embil</td><td valign="middle" align="center" rowspan="1" colspan="1">Autoptic result</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adenovirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b26-mjhid-12-1-e2020039" ref-type="bibr">26</xref>,<xref rid="b27-mjhid-12-1-e2020039" ref-type="bibr">27</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2013, 2016</td><td valign="middle" align="center" rowspan="1" colspan="1">Jaggi, Song</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Herpesvirus 6</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b28-mjhid-12-1-e2020039" ref-type="bibr">28</xref>,<xref rid="b29-mjhid-12-1-e2020039" ref-type="bibr">29</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1989, 1992</td><td valign="middle" align="center" rowspan="1" colspan="1">Okano, Hagiwara</td><td valign="middle" align="center" rowspan="1" colspan="1">Serum antibodies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Parvovirus B19</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b30-mjhid-12-1-e2020039" ref-type="bibr">30</xref>,<xref rid="b45-mjhid-12-1-e2020039" ref-type="bibr">45</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1995, 2019</td><td valign="middle" align="center" rowspan="1" colspan="1">Holm, Maggio</td><td valign="middle" align="center" rowspan="1" colspan="1">Serum antibodies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cytomegalovirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b31-mjhid-12-1-e2020039" ref-type="bibr">31</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2008</td><td valign="middle" align="center" rowspan="1" colspan="1">Usta Guc</td><td valign="middle" align="center" rowspan="1" colspan="1">Serum antibodies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Epstein-Barr virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b32-mjhid-12-1-e2020039" ref-type="bibr">32</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1994</td><td valign="middle" align="center" rowspan="1" colspan="1">Kanegane</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Epstein-Barr virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b33-mjhid-12-1-e2020039" ref-type="bibr">33</xref>,<xref rid="b44-mjhid-12-1-e2020039" ref-type="bibr">44</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">1990, 2019</td><td valign="middle" align="center" rowspan="1" colspan="1">Kikuta, Maggio</td><td valign="middle" align="center" rowspan="1" colspan="1">Serum antibodies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Measles virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b34-mjhid-12-1-e2020039" ref-type="bibr">34</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2000</td><td valign="middle" align="center" rowspan="1" colspan="1">Kuijpers</td><td valign="middle" align="center" rowspan="1" colspan="1">Clinical assessment</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Herpes virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b35-mjhid-12-1-e2020039" ref-type="bibr">35</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2002</td><td valign="middle" align="center" rowspan="1" colspan="1">Shingadia</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Varicella-zoster virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b36-mjhid-12-1-e2020039" ref-type="bibr">36</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2004</td><td valign="middle" align="center" rowspan="1" colspan="1">Lee</td><td valign="middle" align="center" rowspan="1" colspan="1">Clinical assessment</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Influenza virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b37-mjhid-12-1-e2020039" ref-type="bibr">37</xref>,<xref rid="b38-mjhid-12-1-e2020039" ref-type="bibr">38</xref>,<xref rid="b46-mjhid-12-1-e2020039" ref-type="bibr">46</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2011, 2015, 2019</td><td valign="middle" align="center" rowspan="1" colspan="1">Joshi, Huang, Wang</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coxsackie B3 virus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b39-mjhid-12-1-e2020039" ref-type="bibr">39</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2012</td><td valign="middle" align="center" rowspan="1" colspan="1">Rigante</td><td valign="middle" align="center" rowspan="1" colspan="1">Serum antibodies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bocavirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b40-mjhid-12-1-e2020039" ref-type="bibr">40</xref>,<xref rid="b41-mjhid-12-1-e2020039" ref-type="bibr">41</xref>,<xref rid="b42-mjhid-12-1-e2020039" ref-type="bibr">42</xref>,<xref rid="b57-mjhid-12-1-e2020039" ref-type="bibr">57</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2007, 2011, 2014, 2019</td><td valign="middle" align="center" rowspan="1" colspan="1">Catalano-Pons, Santos, Bajolle, L'Huillier</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Torque teno virus 7</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b42-mjhid-12-1-e2020039" ref-type="bibr">42</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2018</td><td valign="middle" align="center" rowspan="1" colspan="1">Thissen</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">New Haven coronavirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b48-mjhid-12-1-e2020039" ref-type="bibr">48</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2005</td><td valign="middle" align="center" rowspan="1" colspan="1">Esper</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronavirus NL63</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b49-mjhid-12-1-e2020039" ref-type="bibr">49</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2006</td><td valign="middle" align="center" rowspan="1" colspan="1">Dominguez</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronavirus 229E</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b50-mjhid-12-1-e2020039" ref-type="bibr">50</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2014</td><td valign="middle" align="center" rowspan="1" colspan="1">Shirato</td><td valign="middle" align="center" rowspan="1" colspan="1">Serum antibodies</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronavirus</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b47-mjhid-12-1-e2020039" ref-type="bibr">47</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2014</td><td valign="middle" align="center" rowspan="1" colspan="1">Chang</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">New coronavirus SARS-CoV-2</td><td valign="middle" align="center" rowspan="1" colspan="1"><xref rid="b51-mjhid-12-1-e2020039" ref-type="bibr">51</xref>,<xref rid="b52-mjhid-12-1-e2020039" ref-type="bibr">52</xref>,<xref rid="b53-mjhid-12-1-e2020039" ref-type="bibr">53</xref>,<xref rid="b54-mjhid-12-1-e2020039" ref-type="bibr">54</xref></td><td valign="middle" align="center" rowspan="1" colspan="1">2020</td><td valign="middle" align="center" rowspan="1" colspan="1">Jones, Rivera-Figueroa, Verdoni, Dufort</td><td valign="middle" align="center" rowspan="1" colspan="1">RT-PCR</td></tr></tbody></table></table-wrap></floats-group></article>